TrialInvestigational new drugs2018

Ketoconazole plus Lenalidomide in patients with Castration-Resistant Prostate Cancer (CRPC): results of an open-label phase II study.

Pedro C Barata et al.PubMed ↗Publisher ↗

No numbers read from the abstract.